BioRestorative Therapies Inc (NASDAQ:BRTX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 63.59. At the close of trading, the stock’s price was $1.52, to imply a decrease of -6.17% or -$0.1 in intraday trading. The BRTX share’s 52-week high remains $2.55, putting it -67.76% down since that peak but still an impressive 32.24% since price per share fell to its 52-week low of $1.03.
BioRestorative Therapies Inc (NASDAQ:BRTX) trade information
After registering a -6.17% downside in the last session, BioRestorative Therapies Inc (BRTX) has traded red over the past five days. The 5-day price performance for the stock is -15.56%, and -35.32% over 30 days. With these gigs, the year-to-date price performance is 6.29%.
BioRestorative Therapies Inc (BRTX) estimates and forecasts
The rating firms project that company’s revenue will grow 471.33% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 475k. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 628k.Earnings reports from the last fiscal year show that sales brought in 19.3k and 35k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 2,361.14% before jumping 1,694.29% in the following quarter.
BRTX Dividends
BioRestorative Therapies Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is STONEX GROUP INC. with 50100.0 shares, or about 0.751% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.1 million.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the BioRestorative Therapies Inc (BRTX) shares. Going by data provided on Dec 31, 2024 , Fidelity Extended Market Index Fund holds roughly 29.11 shares. This is just over 3.34% of the total shares, with a market valuation of $44247.0. Data from the same date shows that the other fund manager holds a little less at 20.47, or 2.35% of the shares, all valued at about 31117.0.
